Cyclin D1 protein expression in lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Cycle Regulation

Background:

• Cyclin D1, a G1 cyclin, plays a role in cell cycle deregulation and oncogenesis.
• Amplification of cyclin D1 (11q13 amplicon) is observed in various cancers, including lung, breast, and head and neck carcinomas.
• Cyclin D1 amplification is increasingly recognized as an indicator of poor prognosis in malignancies.

Purpose of the Study:

• To investigate cyclin D1 protein expression in non-small cell lung carcinomas (NSCLC).
• To correlate cyclin D1 expression with histologic subtype, grade, Ki-67 labeling index, and patient survival.
• To determine the prognostic value of cyclin D1 overexpression in lung cancer.

Main Methods:

• Microwave-enhanced immunohistochemical staining was used to assess cyclin D1 protein expression.
• The study included 102 consecutive cases of lung cancer.
• Data were correlated with histologic subtype, grade, Ki-67 (MIB-1) labeling index, and survival outcomes.

Main Results:

• Nuclear cyclin D1 positive staining was detected in 18% of lung cancer cases.
• Squamous cell carcinoma showed a higher expression rate (21%) compared to adenocarcinoma (9%).
• No significant correlation was found between cyclin D1 overexpression and histologic grade, Ki-67 labeling index, or patient survival.

Conclusions:

• Cyclin D1 protein overexpression may be involved in the oncogenesis of various NSCLC histologic types.
• Cyclin D1 overexpression does not appear to be a useful prognostic marker in lung cancer.
• Further research may elucidate the precise role of cyclin D1 in lung cancer development.